Reference ID: 4110010 - VELCADE
1/38 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VELCADE safely and effectively. See full prescribing information …
Download Reference ID: 4110010 - VELCADE
Information
Domain:
Source:
Link to this page:
Documents from same domain
Understanding your MULTIPLE MYELOMA LAB TESTS
www.velcade.comThis booklet explains common tests for patients with multiple myeloma. Your doctor uses them to help diagnose and assess your multiple myeloma,
VELCADE (bortezomib) for Subcutaneous …
www.velcade.comInjection number Date Comments 1 2 3 4 5 6 7 8 9 10 11 12 VELCADE® (bortezomib) for Subcutaneous Administration Site Tracker This diagram illustrates appropriate sites for subcutaneous administration of VELCADE (bortezomib).
VELCADE®(bortezomib) REIMBURSEMENT …
www.velcade.comVELCADE®(bortezomib) REIMBURSEMENT ASSISTANCE PROGRAM Please complete the information below and fax to the VELCADE Reimbursement Assistance Program at (800) 891-9843 or mail to PO Box 52100, Phoenix,
Prescribing Information | VELCADE® (bortezomib)
www.velcade.comPosterior Reversible Encephalopathy Syndrome: Consider MRI imaging for onset of visual or neurological symptoms; discontinue VELCADE if suspected. (5.5) Gastrointestinal Toxicity: Nausea, diarrhea, constipation, and vomiting may require use of antiemetic and antidiarrheal medications or fluid replacement. (5.6)
Understanding Your Multiple Myeloma Lab Tests
www.velcade.comLAB TESTS . 2 Reference ranges Mark the test values in the column below each date COMPLETE BLOOD COUNT (CBC)1,2 Pages 4-5 White blood cells (WBCs) 3.5-10.5 2 109/L Neutrophils 1.56-6.45 2 109/L Red blood cells (RBCs) Males: 4.32-5.72 2 1012/L Females: 3.90-5.03 2 1012/L Hematocrit
Related documents
VELCADE (bortezomib) for Subcutaneous …
www.velcade.comPlease see full Prescribing Information at velcade.com/Files/PDFs/VELCADE_PRESCRIBING_INFORMATION.pdf
Great-West’s Drug Prior Authorization - CIBP
www.mycibp.caGreat-West Life’s prior authorization process is designed to provide an effective approach to managing claims for specific prescription drugs.